Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The mysterious relation between inflammation and prostate cancer

The mysterious relation between inflammation and prostate cancer AbstractRecent studies showed that inflammation is a critical cause for initiation and/or development of many cancers. In prostate cancer (PC), the inflammatory cells usually populate an immune-competent organ. This inflammatory organ can be involved in the initiation and progression of PC. Here, we mainly focus on the role of inflammation in the PC and progression of castration-resistant PC (CRPC). Moreover, we summarize the roles of inflammation factors (such as chemokines and cytokines) in PC and CRPC. Taken together, this review gives an insight into therapy for PC and CRPC through anti-inflammation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Infection International de Gruyter

The mysterious relation between inflammation and prostate cancer

Zhao, Yu
Infection International , Volume 6 (1): 5 – Nov 28, 2017
Download PDF
5 pages

Loading next page...
 
/lp/de-gruyter/the-mysterious-relation-between-inflammation-and-prostate-cancer-4u8DzuDRM0

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
de Gruyter
Copyright
© 2017 Walter de Gruyter GmbH, Berlin/Boston
eISSN
2544-0349
DOI
10.1515/ii-2017-0154
Publisher site
See Article on Publisher Site

Abstract

AbstractRecent studies showed that inflammation is a critical cause for initiation and/or development of many cancers. In prostate cancer (PC), the inflammatory cells usually populate an immune-competent organ. This inflammatory organ can be involved in the initiation and progression of PC. Here, we mainly focus on the role of inflammation in the PC and progression of castration-resistant PC (CRPC). Moreover, we summarize the roles of inflammation factors (such as chemokines and cytokines) in PC and CRPC. Taken together, this review gives an insight into therapy for PC and CRPC through anti-inflammation.

Journal

Infection International – de Gruyter

Published: Nov 28, 2017

References

  • Prostate cancer as a model for tumour immunotherapy
  • Intraepithelial and stromal lymphocytes in the normal human prostate
  • PET/CT with 18F-choline: physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients: 18F-choline PET/CT bio-distribution and pitfalls, A southern Italian experience
  • Inflammation, infection, and prostate cancer
  • CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancer
  • Expression of several cytokines in prostate cancer: correlation with clinical variables of patients. Relationship with biochemical progression of the malignance
  • Chemokines and chemokine receptors as promoters of prostate cancer growth and progression
  • Inflammation and cancer: back to Virchow?
  • Prostate carcinogenesis and inflammation: emerging insights
  • Inflammation, infection, and prostate cancer
  • Cytokine genetic polymorphisms and prostate cancer aggressiveness
  • A unique cellular and molecular microenvironment is present in tertiary lymphoid organs of patients with spontaneous prostate cancer regression
  • Prostate cancer
  • Proinflammatory cytokine interleukin-6 in prostate carcinogenesis
  • Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach
  • IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer
  • Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy
  • A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment
  • Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
  • Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach
  • The role of inflammation in prostate cancer
  • Linking inflammation and neuroendocrine differentiation : the role of macrophage migration inhibitory factor - mediated signaling in prostate cancer
    Savoy
  • Chemokines and chemokine receptors as promoters of prostate cancer growth and progression
  • The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation
  • CC chemokine ligand 18 correlates with malignant progression of prostate cancer
  • CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancer
  • Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer
  • Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
  • Neutralizing tumor-promoting chronic inflammation: a magic bullet?
  • SUMO-specific protease 1 promotes prostate cancer progression and metastasis
  • Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels
  • Interleukin 32, inflammation and cancer
  • Inflammation in prostate carcinogenesis
  • Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy
  • Interleukin 32, inflammation and cancer
  • Inflammation and prostate cancer
  • Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer?
  • Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells
  • CCL2 chemokine as a potential biomarker for prostate cancer: a pilot study
  • Intraepithelial and stromal lymphocytes in the normal human prostate
  • The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)
  • Inflaming gastrointestinal oncogenic programming
  • Glucose metabolism in the progression of prostate cancer
  • Cancer: an inflammatory link
  • Prostate cancer as a model for tumour immunotherapy
  • Targeting Th17-IL-17 pathway in prevention of micro-invasive prostate cancer in a mouse model
  • Role of inflammasomes and their regulators in prostate cancer initiation, progression and metastasis
  • Expression of several cytokines in prostate cancer: correlation with clinical variables of patients. Relationship with biochemical progression of the malignance
  • De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
  • Proinflammatory cytokine interleukin-6 in prostate carcinogenesis
  • From inflammation to prostate cancer: the role of inflammasomes
  • Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach
  • Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue
  • Glucose metabolism in the progression of prostate cancer
  • Targeting Th17-IL-17 pathway in prevention of micro-invasive prostate cancer in a mouse model
  • Inflammation and cancer
  • IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressiveness
  • Role of inflammasomes and their regulators in prostate cancer initiation, progression and metastasis
  • IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer
  • Inflammation and cancer
  • The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation
  • Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue
  • De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
  • Inflaming gastrointestinal oncogenic programming
  • Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach
  • Neutralizing tumor-promoting chronic inflammation: a magic bullet?
  • Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels
  • The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)
  • A unique cellular and molecular microenvironment is present in tertiary lymphoid organs of patients with spontaneous prostate cancer regression
  • Inflammation, cardiometabolic markers, and functional changes in men with prostate cancer. A randomized controlled trial of a 12-month exercise program
  • Chronic prostatitis – an infectious disease?
  • Inflammation, cardiometabolic markers, and functional changes in men with prostate cancer. A randomized controlled trial of a 12-month exercise program
  • Chronic prostatitis – an infectious disease?
  • Cytokine genetic polymorphisms and prostate cancer aggressiveness
  • PET/CT with 18F-choline: physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients: 18F-choline PET/CT bio-distribution and pitfalls, A southern Italian experience
  • Inflammation and cancer: back to Virchow?
  • Inflammation and chronic prostatic diseases: evidence for a link?
  • Cancer: an inflammatory link
  • IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressiveness
  • Inflammation and prostate cancer
  • Prostate growth and inflammation
  • Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells
  • IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer
  • IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer
  • Prostate carcinogenesis and inflammation: emerging insights
  • CC chemokine ligand 18 correlates with malignant progression of prostate cancer
  • Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer
  • Prostate cancer
  • The role of inflammation in prostate cancer
  • CCL2 chemokine as a potential biomarker for prostate cancer: a pilot study
  • Linking inflammation and neuroendocrine differentiation : the role of macrophage migration inhibitory factor - mediated signaling in prostate cancer
    Savoy
  • Inflammation and chronic prostatic diseases: evidence for a link?
  • Prostate growth and inflammation
  • Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer?
  • From inflammation to prostate cancer: the role of inflammasomes
  • Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells
  • A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment
  • Inflammation in prostate carcinogenesis
  • SUMO-specific protease 1 promotes prostate cancer progression and metastasis
  • Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells